Ziarco nets $33.1 mln Series B

Ziarco has closed $33.1 million in Series B funding. New Enterprise Associates and Lundbeckfond Ventures led the round. In addition to the funding, Ed Mathers, a partner at NEA, has been appointed chairman of Ziarco's board of directors. Also, Johan Kördel, a senior partner at Lundbeckfond Ventures, has been added to the board. Ziarco is a biopharmaceutical firm focused on inflammatory skin diseases.

North AmericaUSBriefs